Insider Trading & Ownership of Michael Aaron Kelly

Location
New York, NY
Summary
The estimated net worth of Michael Aaron Kelly is at least $1,211,783 dollars as of 27 Apr 2026. Michael Aaron Kelly is the Director of NEOGENOMICS INC and owns shares of NEOGENOMICS INC (NEO) stock worth about $785.2K. Michael Aaron Kelly is the Director of DMC Global Inc. and owns shares of DMC Global Inc. (BOOM) stock worth about $409.7K. Michael Aaron Kelly is the Director of Aprea Therapeutics, Inc. and owns shares of Aprea Therapeutics, Inc. (APRE) stock worth about $17K.
Signature
/s/ Christian Formica, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Michael Aaron Kelly and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • Michael Aaron Kelly has 6 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,211,783.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: NEOGENOMICS INC ($785,156).
  • Past-year value change for that position: +$38,000.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Michael Aaron Kelly

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NEO NEOGENOMICS INC Director $785,156 +$38,000 +5.1% 01 Jun 2025
BOOM DMC Global Inc. Director $409,658 14 May 2025
APRE Aprea Therapeutics, Inc. Director $16,969 30 Jun 2021
FOLD AMICUS THERAPEUTICS, INC. Director $0 27 Apr 2026
HOOK HOOKIPA Pharma Inc. Director 30 Jun 2022
PRME Prime Medicine, Inc. Director 01 Aug 2025

Insider Transactions Reported by Michael Aaron Kelly:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .